5781 - 5790 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.001Citation Count: 50
- Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)2017OPENTitle: Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)Journal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e016904End Page: e016904Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-016904Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e016904.full.pdfCitation Count: 6
-
RESTRICTEDTitle: Targeting urate to reduce oxidative stress in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 210End Page: 224Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.06.017Best OA location URL: http://manuscript.elsevier.com/S0014488617301577/pdf/S0014488617301577.pdfCitation Count: 103
-
RESTRICTEDTitle: Therapeutic approaches to target alpha-synuclein pathologyJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 225End Page: 235Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.003Best OA location URL: http://manuscript.elsevier.com/S0014488617302455/pdf/S0014488617302455.pdfCitation Count: 192
- A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain2017OPENTitle: A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brainJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 48End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201708202Best OA location URL: https://doi.org/10.15252/emmm.201708202Citation Count: 136
- Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation2017OPENTitle: Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin DownregulationJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 9Issue #: 6Start Page: 1853End Page: 1867Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2017.10.029Best OA location URL: http://www.cell.com/article/S2213671117304848/pdfCitation Count: 44
- Applying a community-based participatory research framework to patient and family engagement in the development of patient-centered outcomes research and practice2017RESTRICTEDTitle: Applying a community-based participatory research framework to patient and family engagement in the development of patient-centered outcomes research and practiceJournal Name: Translational Behavioral MedicinePublisher: Oxford University Press (OUP)Vol: 8Issue #: 5Start Page: 683End Page: 691Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/tbm/ibx026Best OA location URL: https://academic.oup.com/tbm/article-pdf/8/5/683/25699129/ibx026.pdfCitation Count: 72
- Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?2017OPENTitle: Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?Journal Name: EJNMMI PhysicsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40658-017-0196-1Best OA location URL: https://ejnmmiphys.springeropen.com/track/pdf/10.1186/s40658-017-0196-1Citation Count: 31
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
-
OPENTitle: Exploring the reproducibility of functional connectivity alterations in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 11Start Page: e0188196End Page: e0188196Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0188196Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0188196&type=printableCitation Count: 62